Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Anil K. Bhandari"'
Autor:
Anil K. Bhandari, Junaid A.B. Zaman
Publikováno v:
Journal of cardiovascular pharmacology and therapeutics. 24(6)
The role of oral anticoagulants (OAC) in atrial fibrillation (AF) is well established. However, none of the randomized controlled trials included patients with end-stage renal disease (ESRD) leaving a lack of evidence in this large, challenging and u
Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia
Autor:
Timm Dickfeld, Anil K. Bhandari, Claudio Schuger, Mario D. Gonzalez, Henry H. Hsia, Charles I. Haffajee, Francis E. Marchlinski, Frank Bogun, Karen J. Beckman, Scott J. Pollak, John F. Beshai
Publikováno v:
Journal of the American College of Cardiology. 67:674-683
Background Radiofrequency catheter ablation is used to treat recurrent ventricular tachycardia (VT). Objectives This study evaluated long-term safety and effectiveness of radiofrequency catheter ablation using an open-irrigated catheter. Methods Pati
Publikováno v:
EP Europace. 16:1007-1014
Aims The step-wise approach to catheter ablation for persistent atrial fibrillation (AF) requires considerable substrate modification targeting at complex fractionated atrial electrograms (CFAEs) in addition to pulmonary vein (PV) isolation. An alter
Autor:
Christina Economides, Anil K. Bhandari, Robert A. Kloner, Bryan G. Schwartz, Steven Burstein, David S. Cannom, Guy S Mayeda, William J. French
Publikováno v:
International Journal of Clinical Practice. 66:631-639
SUMMARY Aims: To describe the relation between emotional stress and cardiovascular events, and review the literature on the cardiovascular effects of emotional stress, in order to describe the relation, the underlying pathophysiology, and potential t
Autor:
Donna Godejohn, Steve Lewis, Matthew R. Reynolds, John A. Spertus, Dhanunjaya Lakkireddy, Anil K. Bhandari, Alan P. Wimmer, Caroline Burk, Paul Dorian, Rosemary S. Bubien
Publikováno v:
Circulation: Arrhythmia and Electrophysiology. 4:15-25
Background— Atrial fibrillation (AF) has a deleterious impact on health-related quality-of-life (HRQoL), but measuring this outcome is difficult. A comprehensive, validated, disease-specific questionnaire to measure the spectrum of QoL domains affe
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics. 16:192-196
Introduction: There are few safe antiarrhythmics for ischemic heart disease. Whereas ranolazine is a promising late INa blocker with antiarrhythmic effects, and devoid of pro-arrhythmic properties, there are no direct comparisons between ranolazine a
Autor:
David S. Cannom, Anil K. Bhandari, Mitsuharu Kawamura, Hiroshi Tada, Ivan Ho, Miki Yokokawa, Atsushi Suzuki
Publikováno v:
Pacing and Clinical Electrophysiology. 34:15-22
Background: The relationship between the applied techniques and clinical outcomes after radiofrequency (RF) ablation of atrial fibrillation (AF) remains unclear. We compared the results of ablation by RF delivered via a point-by-point versus catheter
Publikováno v:
Cardiovascular Therapeutics. 29:e36-e41
SUMMARY Background: The antianginal agent ranolazine (R) has shown some promise as an antiarrhythmic agent but its mechanism of action is not known. Previously, we have shown that R suppresses ventricular arrhythmias at a concentration >10 μM that m
Autor:
Joan Dow, Anil K. Bhandari, Robert A. Kloner, Wei-Qun Wang, John C. Shryock, Arvinder K. Dhalla, Luiz Belardinelli
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 297:H1923-H1929
We tested the effect of the antianginal agent ranolazine on ventricular arrhythmias in an ischemic model using two protocols. In protocol 1, anesthetized rats received either vehicle or ranolazine (10 mg/kg, iv bolus) and were subjected to 5 min of l
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics. 14:99-103
We have observed that ischemic postconditioning markedly reduces reperfusion-induced ventricular arrhythmias, but whether the mechanism is related to previously described pathways of preconditioning or postconditioning for infarct size reduction is u